Infection

, Volume 26, Issue 3, pp 144–150

In vitro conversion ofBorrelia burgdorferi to cystic forms in spinal fluid, and transformation to mobile spirochetes by incubation in BSK-H medium

  • Ø. Brorson
  • S. H. Brorson
Clinical and Epidemiological Studies Originalia

Summary

The purpose of this study was to examine the structural alterations ofBorrelia burgdorferi when exposed to spinal fluid. Normal, mobile spirochetes were inoculated into spinal fluid, and the spirochetes were converted to cysts (spheroplast L-forms) after 1–24 h. When these cystic forms were transferred to a rich BSK-H medium, the cysts were converted back to normal, mobile spirochetes after incubation for 9 to 17 days. The cultures were examined by dark field microscopy (DFM), interference contrast microscopy (ICM) and transmission electron microscopy (TEM). When neuroborreliosis is suspected, it is necessary to realize thatB. burgdorferi can be present in a cystic form, and these cysts have to be recognized by microscopy. This study may also explain why cultivation of spinal fluid often is negative with respect toB. burgdorferi.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barbour, A. G., Fish, D.: The biological and social phenomenon of Lyme disease. Science 260 (1993) 1610–1616.PubMedCrossRefGoogle Scholar
  2. 2.
    Luft, B. J., Steinman, C. R., Neimark, H. G., Muralidhar, B., Rush, T., Finkel, M. F., Kunkel, M., Dattwyler, R. J.: Invasion of the central nervous system byBorrelia burgdorferi in acute disseminated infection. JAMA 267 (1992) 1364–1367.PubMedCrossRefGoogle Scholar
  3. 3.
    Stiernstedt, G.: Tick-borneBorrelia infection in Sweden. Scand. J. Infect. Dis. 45 (Suppl.) (1985) 1–70.Google Scholar
  4. 4.
    Christen, H. J., Hanefeld, F., Eiffert, H., Thomssen, R.: Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatrica Suppl. 82 (1993) 386.CrossRefGoogle Scholar
  5. 5.
    Keller, T. L., Halperin, J. J., Whitman, M.: PCR detection ofBorrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients. Neurology 42 (1992) 32–42.PubMedGoogle Scholar
  6. 6.
    Logigian, E. L., Kaplan, R. F., Steere, A. C.: Chronic neurological manifestations of Lyme disease. N. Engl. J. Med. 323 (1990) 1438–1444.PubMedCrossRefGoogle Scholar
  7. 7.
    Halperin, J. J., Volkman, D. J., Wu, P.: Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 41 (1991) 1571–1582.PubMedGoogle Scholar
  8. 8.
    Preac Mursic, V., Weber, K., Pfister, H. W., Wilske, B., Gross, B., Baumann, A., Prokop, J.: Survival ofBorrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 17 (1989) 355–359.PubMedCrossRefGoogle Scholar
  9. 9.
    Oksi, J., Marjamaki, M., Koski, K., Nikoskelainen, J., Viljanen, M. K.: Bilateral facial palsy and meningitis caused byBorrelia double infection. Lancet 345 (1995) 1583–1584.PubMedCrossRefGoogle Scholar
  10. 10.
    Pfister, H. W., Preac Mursic, V., Wilske, B., Einhäupl, K. M., Weinberger, K.: Latent Lyme neuroborreliosis: presence ofBorrelia burgdorferi in the cerebrospinal fluid without concurrent inflammatory signs. Neurology 39 (1989) 1118–1120.PubMedGoogle Scholar
  11. 11.
    Karlsson, M., Hammers-Berggren, S., Lindquist, L., Stiernstedt, G., Svenungsson, B.: Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 44 (1994) 1203–1207.PubMedGoogle Scholar
  12. 12.
    Karlsson, M.: Aspects of the diagnosis of Lyme borreliosis. Scand. J. Infect. Dis. 67 (1990) (Suppl.) 1–59.Google Scholar
  13. 13.
    Åsbrink, E., Hovmark, A., Hederstedt, B.: The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm. Venerol. 64 (1984) 506–512.PubMedGoogle Scholar
  14. 14.
    Pollack, R. J., Telford, S. R., Spielman, A.: Standardization of medium for culturing Lyme disease spirochetes. J. Clin. Microbiol. 31 (1993) 1251–1255.PubMedGoogle Scholar
  15. 15.
    Hammers-Berggren, S., Lebech, A. M., Karlsson, M., Svenungsson, B., Hansen, K., Stiernstedt, G.: Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J. Clin. Microbiol. 32 (1994) 1519–1525.PubMedGoogle Scholar
  16. 16.
    Brorson, Ø., Brorson, S. H.: Transformation of cystic forms ofBorrelia burgdorferi to normal mobile spirochetes. Infection 25 (1997) 240–246.PubMedCrossRefGoogle Scholar
  17. 17.
    Jobe, D. A., Callister, S. M., Schell, R. F.: Recovery ofBorrelia burgdorferi by filtration. J. Clin. Microbiol. 31 (1993) 1896–1897.PubMedGoogle Scholar
  18. 18.
    Brorson, S. H., Skjørten, F.: Mechanism for antigen detection on deplasticized epoxy sections. Micron 26 (1995) 301–310.PubMedCrossRefGoogle Scholar
  19. 19.
    Brorson, S. H., Strøm, E. H., Skjørten, F.: Immunoelectron microscopy on epoxy sections without deplasticizing to detect glomerular immunoglobulin and complement deposits in renal diseases. APMIS 105 (1997) 139–149.PubMedCrossRefGoogle Scholar
  20. 20.
    Garon, C. F., Dorward, D. W., Corwin, M. D.: Structural features ofBorrelia burgdorferi—the Lyme disease spirochete: silver staining for nucleic acids. Scanning Microsc. 3 (Suppl.) (1989) 109–115.Google Scholar
  21. 21.
    Bruck, D. K., Talbot, M. L., Cluss, R. G., Boothby, J. T.: Ultrastructural characterization of the stages of spheroplast preparation ofBorrelia burgdorferi. J. Microbiol. Methods 23 (1995) 219–228.CrossRefGoogle Scholar
  22. 22.
    Schaller, M., Neubert, U.: Ultrastructure ofBorrelia burgdorferi after exposure to benzylpenicillin. Infection 22 (1994) 401–406.PubMedCrossRefGoogle Scholar
  23. 23.
    Coyle, P. K., Deng, Z., Schutzer, S. E., Belman, A. L., Benach, J., Krupp, L. B., Luft, B.: Detection ofBorrelia-burgdorferi, antigens in cerebrospinal fluid. Neurology 43 (1993) 1093–1097.PubMedGoogle Scholar
  24. 24.
    Schutzer, S. E., Coyle, P. K., Belman, A. L., Golightly, M. G., Drulle, J.: Sequestration of antibody toBorrelia burgdorferi in immune complexes in seronegative Lyme disease. Lancet 335 (1990) 312–315.PubMedCrossRefGoogle Scholar
  25. 25.
    Tatro, J. B., Romero, L. I., Beasley, D., Steere, A. C., Reichlin, S.:Borrelia burgdorferi andEscherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. J. Infect. Dis. 169 (1994) 1014–1022.PubMedGoogle Scholar
  26. 26.
    Defosse, D. L., Johnson, R. C.:In vitro andin vivo induction of tumor necrosis factor alpha byBorrelia burgdorferi. Infect. Immun. 60 (1992) 1109–1113.PubMedGoogle Scholar
  27. 27.
    Miller, L. C., Isa, S., Vannier, E., Georgilis, K., Steere, A. C., Dinarello, C. A.: LiveBorrelia burgdorferi preferentially activate interleukin-1b gene expression and protein synthesis over the interleukin-1 receptor antagonist. J. Clin. Invest. 90 (1992) 906–912.PubMedCrossRefGoogle Scholar
  28. 28.
    Hardin, J. A., Steere, A. C., Malawista, S. E.: Immune complexes and the evolution of Lyme arthritis. Dissemination and localisation of abnormal C1q binding activity. N. Engl. J. Med. 301 (1979) 1358–1363.PubMedCrossRefGoogle Scholar
  29. 29.
    Høiby, N., Doring, G., Schiøtz, P. O.: The role of immune complexes in the pathogenesis of bacterial infections. Ann. Rev. Microbiol. 40 (1986) 29–53.Google Scholar
  30. 30.
    Beck, G., Benach, J. L., Habicht, G. S.: Isolation, preliminary chemical characterization, and biological activity ofBorrelia burgdorferi peptidoglycan. Biochem. Biophys. Res. Commun. 167 (1990) 89–95.PubMedCrossRefGoogle Scholar
  31. 31.
    Radolf, J. D., Arndt, L. L., Akins, D. R., Curetty, L. L., Levi, M. E., Shen, Y., Davis, L. S., Norgard, M. V.:Treponema pallidum, andBorrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154 (1995) 2866–2877.PubMedGoogle Scholar
  32. 32.
    Sadziene, A., Rosa, P. A., Thompson, P. A., Hogan, D. M., Barbour, A. G.: Antibody-resistant mutants ofBorrelia burgdorferi: in vitro selection and characterization. J. Exp. Med. 176 (1992) 799–809.PubMedCrossRefGoogle Scholar
  33. 33.
    Burgdorfer, W., Schwan, T. G.: Lyme borreliosis: a relapsing feverlike disease? Scand. J. Infect. Dis. 77 (1991) (Suppl.) 17–22.Google Scholar
  34. 34.
    MacDonald, A. B.: Concurrent neocortical borreliosis and Alzheimer’s disease. Ann. N. Y. Acad. Sci. 539 (1988) 468–470.CrossRefGoogle Scholar
  35. 35.
    Hulínská, D., Barták, P., Hercogová, J., Hancil, J., Basta, J., Schramlová, J.: Electron microscopy of Langerhans cells andBorrelia burgdorferi in Lyme disease patients. Zbl. Bakt. 280 (1994) 348–359.Google Scholar
  36. 36.
    Kersten, A., Poitschek, S., Rauch, S., Aberer, E.: Effects of penicillin, ceftriaxone, and doxycycline on morphology ofBorrelia burgdorferi. Antimicrob. Agents Chemother. 39 (1995) 1127–1133.PubMedGoogle Scholar
  37. 37.
    Preac Mursic, V., Wanner, G., Reinhardt, S., Wilske, B., Busch, U., Marget, W.: Formation and cultivation ofBorrelia burgdorferi spheroplast-L-form variants. Infection 24 (1996) 218–226.CrossRefGoogle Scholar
  38. 38.
    Grüner, E. S.: Complement evasion by the Lyme disease spirocheteBorrelia burgdorferi grown in host-derived tissue co-cultures: role of fibronectin in complement-resistance. Experientia 52 (1996) 364–372.CrossRefGoogle Scholar
  39. 39.
    Georgilis, K., Peacocke, M., Klempner, M. S.: Fibroblasts protect the Lyme disease spirochete,Borrelia burgdorferi, from ceftriaxonein vitro. J. Infect. Dis. 166 (1992) 440–444.PubMedGoogle Scholar
  40. 40.
    Priem, S., Rittig, M. G., Kamradt, T., Burmester, G. R., Krause, A. J.: An optimized PCR leads to rapid and highly sensitive detection ofBorrelia burgdorferi in patients with Lyme borreliosis. Clin. Microbiol. 35 (1997) 685–690.Google Scholar
  41. 41.
    Peters, D. J., Benach, J. L.:Borrelia burgdorferi adherence and injury to undifferentiated and differentiated neural cellsin vitro. J. Infect. Dis. 176 (1997) 470–477.PubMedCrossRefGoogle Scholar

Copyright information

© MMV Medizin Verlag GmbH München 1998

Authors and Affiliations

  • Ø. Brorson
    • 1
  • S. H. Brorson
    • 2
  1. 1.Dept. of MicrobiologyVestfold SentralsykehusTønsbergNorway
  2. 2.Dept. of PathologyUlleval University HospitalOsloNorway

Personalised recommendations